Advisory Research Inc Maxcyte, Inc. Transaction History

Advisory Research Inc

  • $487 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$2.6 - $5.24 $111,399 - $224,513
42,846 New
42,846 $201,000
Q4 2022

Feb 13, 2023
SELL
$4.92 - $7.4 $40,373 - $60,724
-8,206 Reduced 23.17%
27,204 $148,000
Q3 2022

Nov 14, 2022
BUY
$4.52 - $6.51 $160,053 - $230,519
35,410 New
35,410 $230,000

Others Institutions Holding MXCT

# of Institutions
126
Shares Held
62M
Call Options Held
2.4K
Put Options Held
2.1K
View Full List

About MAXCYTE, INC.

MXCT Quotes by TradingView
  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $412M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email